---
name: iXCells Biotechnologies
slug: ixcells-biotechnology
site: cro
website_domain: ixcellsbiotech.com
summary: Offers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery.
tagline: iPSC models, primary cells, and preclinical in vitro CRO services for drug discovery
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-11-13T11:00:47.358Z
services_count: 3
modalities_count: 1
indications_count: 1
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# iXCells Biotechnologies

iPSC models, primary cells, and preclinical in vitro CRO services for drug discovery

Listed on cro.directory.

## Summary

Offers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery.

## Services

- Discovery Research
- Preclinical In Vitro Studies
- In Vitro Pharmacology

## Modalities

- Oligonucleotide

## Indications

- Neurology

## Long description

## Overview

iXCells Biotechnologies describes itself as a preclinical drug discovery company focused on disease-relevant cellular models. Its website pairs a catalog of iPSCs, iPSC-derived cells, and primary cells with fee-for-service preclinical CRO services.

## Preclinical CRO services

- iPSC reprogramming of somatic cells into characterized iPSC lines using non-integrating methods
- Cas9 genome editing, including isogenic disease models and precision target validation
- Directed differentiation of iPSCs into neurons, cardiomyocytes, hepatocytes, and other cell types
- Custom cell isolation tailored to tissue source, donor criteria, and application
- In vitro bioassays, complex assay development, and antisense oligonucleotide (ASO) screening
- Multi-cellular model building, 3D liver model signaling studies, and compound screening in iPSC-derived neurons and human immune cells

## Scientific approach

The website states that the team includes PhD scientists and that the company offers patent-derived models intended to accelerate drug discovery and disease understanding. It also describes high-throughput iPSC screening platforms and an all-in-one iPSC platform (iPSCore) for generating human-relevant models.

## Similar companies

- [Axxam](/companies/axxam) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/axxam/ixcells-biotechnology)
- [Scantox](/companies/scantox) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/ixcells-biotechnology/scantox)
- [Alloy Therapeutics](/companies/alloytx) (Discovery Research, In Vitro Pharmacology) — [Compare](/compare/alloytx/ixcells-biotechnology)
- [Avigen Ltd](/companies/avigen) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/avigen/ixcells-biotechnology)
- [Nexus BioQuest](/companies/nexus-bioquest) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/ixcells-biotechnology/nexus-bioquest)
- [Distolife](/companies/distolife-shanghai-co-ltd) (Discovery Research) — [Compare](/compare/distolife-shanghai-co-ltd/ixcells-biotechnology)
- [STEMCELL Technologies Inc.](/companies/stemcell) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/ixcells-biotechnology/stemcell)
- [ChemDiv](/companies/chemdiv) (Discovery Research, Preclinical In Vitro Studies) — [Compare](/compare/chemdiv/ixcells-biotechnology)

_Profile last updated: 2026-11-13T11:00:47.358Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.